Understanding how certain molecules are broken down in T-cell leukemia
Exploring microRNA degradation in T-cell acute lymphoblastic leukemia
This project looks at how tiny molecules called microRNAs are controlled in T-cell acute lymphoblastic leukemia to find new ways to fight the disease.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Florida NIH-funded |
| Lab location | 1 site (Gainesville, United States) |
| Project ID | NIH-11136382 on NIH RePORTER |
What this research studies
Our bodies have small molecules called microRNAs that help control how our genes work. In cancer cells, these microRNAs often behave differently, which can help the cancer grow. We recently discovered a surprising way that a common chemotherapy drug, dexamethasone, causes certain cancer-promoting microRNAs to break down in T-cell leukemia cells. This happens because another molecule, called BIM mRNA, triggers their breakdown. We want to understand exactly how this process works and how it helps kill leukemia cells, hoping to develop new treatment strategies.
Who could benefit from this research
Good fit: Patients with T-cell acute lymphoblastic leukemia might eventually benefit from new therapies developed from this fundamental understanding.
Not a fit: Patients with other types of cancer or conditions not related to T-cell acute lymphoblastic leukemia may not directly benefit from this specific research.
Why it matters
Potential benefit: If successful, this work could lead to new ways to target and treat T-cell acute lymphoblastic leukemia by controlling microRNA levels.
How similar studies have performed: This research explores a newly discovered mechanism of gene regulation, representing a novel approach to understanding and potentially treating T-cell leukemia.
Where this research is happening
Gainesville, United States
- University of Florida — Gainesville, United States (Active)
Researchers
- Principal investigator: Xie, Mingyi — University of Florida
- Study coordinator: Xie, Mingyi
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.